NCT07762443Phase 1Not yet recruiting
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata
A Phase I Study to Evaluate the Pharmacokinetics, Safety, and Preliminary Efficacy of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata
In the register
The register attaches this trial to VC005 (Jiangsu Vcare Pharmaceutical), currently at “Phase 2” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Phase 1
- Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Participants (registry)
- 24
- Start
- September 2026 (planned)
- Primary completion
- December 2027 (planned)
- Study completion
- December 2027 (planned)
- Last registry update
- August 2026
- Countries
- China
Conditions studied: Alopecia Areata
Interventions: VC005 tablets
Other trials of VC005
Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.